MOKSHA8 PHARMACEUTICALS
Drug Stores & Pharmacies · New Jersey, United States · 201-500 Employees
View Company Info for Free
Overview
Headquarters
13 Hilltown Ct, Plainsboro, New Jersey, ...Phone Number
(610) 727-4018Website
www.moksha8.comRevenue
$25.9 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About MOKSHA8 PHARMACEUTICALS
Moksha8, founded in 2007 and based in Berwyn, PA, is a Latin American pharmaceutical company, with a core focus on commercializing the highest quality medicines with best in class operations and strong FCPA compliance. The company launched its commercial operations in 2008 in Brazil and Mexico promoting primarily CNS products. Moksha8 has a broad alliance with Forest Laboratories throughout Latin America and partnerships with GSK, Sandoz, Aurobindo and Accord in Brazil. The company was founded by Simba Gill and TPG Biotechnology.Explore more
MOKSHA8 PHARMACEUTICALS Org Chart
Get the full picture
Sign in to uncover key details.
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is MOKSHA8 PHARMACEUTICALS your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
MOKSHA8 PHARMACEUTICALS, which may be a good buyer, showed buying intent in Masked Content Topic
Website visits: Recent activity has been detected on your website
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Funding: Get notified immidiatlly once MOKSHA8 PHARMACEUTICALS has new funding data
Check if MOKSHA8 PHARMACEUTICALS has recently received funding, and reach out quickly before it becomes old news!
Check out if MOKSHA8 PHARMACEUTICALS is spiking on competitors!
Earning: See what the market has to say on MOKSHA8 PHARMACEUTICALS recently announced quarterly report
Product Launch: Get notified when MOKSHA8 PHARMACEUTICALS launches new products
Click to see if MOKSHA8 PHARMACEUTICALS had a recent Job posting/layoffs
Congratulate Masked Content for being promoted to Masked Content at MOKSHA8 PHARMACEUTICALS
Recommended Actions
Find VP level buyers at MOKSHA8 PHARMACEUTICALS
Find 2 more new buyers
Compare Similar Companies to MOKSHA8 PHARMACEUTICALS
Compare insights from companies similar to MOKSHA8 PHARMACEUTICALS, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
MOKSHA8 PHARMACEUTICALS is experiencing very low activity levels compared to other companies in the Retail sector.
What does this means?
MOKSHA8 PHARMACEUTICALS is drawing exceptional interest within the Retail industry, suggesting notable developments or strong market momentum, learn more about MOKSHA8 PHARMACEUTICALS.
MOKSHA8 PHARMACEUTICALS financials insights
Gather financial insights about MOKSHA8 PHARMACEUTICALS, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2008
Series A
$39M
2009
Series B
$25.1M
2010
Series C
$30M
2012
Unspecified
$125M
MOKSHA8 PHARMACEUTICALS Tech Stack
A closer look at the technologies used by MOKSHA8 PHARMACEUTICALS
MOKSHA8 PHARMACEUTICALS News & Media
Knight Signs GUD (Bueno) Latin American Strategic Funding Deal with Moksha8
MONTREAL and BERWYN, Pa., Feb. 18, 2019 (GLOBE NEWSWIRE) -- Knight Therapeutics Inc. (TSX: GUD) ("Knight"), a Canadian specialty pharmaceutical company focused on acquiring, in-licensing, selling and marketing innovative prescription pharmaceutical products and Moksha8 Inc. (“Moksha8”), a specialty pharmaceutical company focused on licensing and marketing innovative and established therapeutics in Latin America, today announced the closing of a strategic financing agreement for up to US$125 millKnight Signs GUD (Bueno) Latin American Strategic Funding Deal with Moksha8
MONTREAL and BERWIN, Pennsylvania, Feb. 18, 2019 /PRNewswire/ -- Knight Therapeutics Inc. (TSX: GUD) ("Knight"), a Canadian specialty pharmaceutical company focused on acquiring, in-licensing, selling and marketing innovative prescription pharmaceutical products and Moksha8 Inc....Knight Signs GUD (Bueno) Latin American Strategic Funding Deal with Moksha8
MONTREAL and BERWYN, Pa., Feb. 18, 2019 (GLOBE NEWSWIRE) -- Knight Therapeutics Inc. (TSX: GUD) ("Knight"), a Canadian specialty pharmaceutical company focused on acquiring, in-licensing, selling and marketing innovative prescription pharmaceutical products and Moksha8 Inc. (“Moksha8”), a specialty pharmaceutical company focused on licensing and marketing innovative and established therapeutics in Latin America, today announced the closing of a strategic financing agreement for up to US$125 mill
Read more news
Top Drug Stores & Pharmacies Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding MOKSHA8 PHARMACEUTICALS
Sign Up For FreeTo access detailed company insights
Moksha8, founded in 2007 and based in Berwyn, PA, is a Latin American pharmaceutical company, with a core focus on commercializing the highest quality medicines with best in class operations and strong FCPA compliance. The company launched its commercial operations in 2008 in Brazil and Mexico promoting primarily CNS products. Moksha8 has a broad a... Read More
